Bright Minds Biosciences Inc. Gains 21.38%
Fri, Sep 02, 2022 at 07:20 PM
Bright Minds Biosciences Inc. (DRUG:NASDAQ) rocketted at $1.93, representing a gain of 21.4%. The stock got featured on our News Catalysts scanner on Wed, Aug 31, 2022 at 10:22 AM in the 'BIOTECH' category. From Fri, Aug 19, 2022, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Aug 26, 2022 at $4.16 with a volume of 106M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Venus Concept Inc. (VERO:NASDAQ), 54.87%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- PaxMedica Inc. (PXMD:NASDAQ), 47.71%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 35.29%
- Sunrise New Energy Co. Ltd Ord (EPOW:NASDAQ), 31.46%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 29.1%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 23.39%
- Pear Therapeutics Inc. (PEAR:NASDAQ), 21.71%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 21.38%
- New Age Beverages Corporation (NBEV:NASDAQ), 21.28%